SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

MullenArmy is actively discussing a speculative push for the MULN crypto token, heavily associating it with simultaneous promotional campaigns for the DARTH symbol and various SOL-based meme coin projects. The community remains deeply polarized, with proponents rallying behind aggressive buying and rotation tactics while critics dismiss the activity as a high-risk pump-and-dump scheme reminiscent of past stock market volatility.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

The Kendu community is actively promoting the project's expansion into real-world initiatives, ranging from branded consumer goods like energy drinks and spices to sports sponsorships. Investors are highlighting the brand's consistent building efforts and organic growth as key drivers for long-term confidence.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is trending as traders speculate on potential ecosystem developments and technical breakout patterns, with the community actively debating whether it is a long-term utility play or a cyclical pump-and-dump scheme. Discussion is dominated by polarized sentiment between long-term holders accumulating through price volatility and vocal critics questioning the project's transparency and delivery on milestones.

TOSHI

TOSHI is trending as investors speculate on potential exchange listings and its role in the Base ecosystem, with the community actively sharing bullish sentiment and accumulating tokens despite recent price volatility. Traders are closely monitoring key support levels and volume shifts, viewing current price action as a coiling phase ahead of an anticipated breakout.

Spitcoin is a community-driven cryptocurrency built on the Solana blockchain that powers a decentralized creator economy through the LimitlessFlo platform.  The project focuses on giving creators full control over their content and earnings by enabling instant monetization from day one—through tips, subscriptions, live streaming, and marketplace transactions—without the restrictions of traditional platforms like bans, algorithm suppression, or delayed payouts.  At its core, Spitcoin is about combining meme culture with real utility, creating a self-sustaining ecosystem where platform activity drives token demand, and token usage fuels platform growth.

SpitCoin

SpitCoin is gaining traction as community members highlight its role in powering the LimitlessFlo platform and its frequent association with WAGMI. Investors are actively tracking the project for potential upward momentum while circulating specific contract information to increase visibility across social platforms.

Hormuz Toll Fund (HTF) is a community-driven SPL token deployed on the Solana blockchain. The project takes its name and visual identity from the Strait of Hormuz, the maritime corridor through which a significant share of global seaborne crude oil transits, and adopts an energy and shipping-toll motif as the basis for its branding and community culture. Despite the word "Fund" in its name, HTF is not an investment fund, security, or pooled investment vehicle, and the project holds no physical commodity, oil contracts, or shipping rights of any kind. It is not affiliated with any government, maritime authority, or shipping entity. The token follows the standard Solana SPL fungible token model and trades on Solana-native decentralized exchanges with all transfers and balances publicly verifiable on-chain.

Hormuz Toll Fund

Hormuz Toll Fund is gaining traction as traders speculate on the project's long-term utility and potential for higher time frame growth.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is attracting significant attention as investors monitor its lead drug candidate, ivonescimab, which is undergoing an FDA BLA review with a decision expected later this year. The community remains highly focused on the company's clinical pipeline and upcoming ASCO presentation, with many viewing the stock's recent volatility as a consolidation phase before potentially impactful regulatory and trial milestones.

GIGA is a meme token deployed on the Solana blockchain intended to honor the legend Ernest Khalimov the original “Gigachad”, by utilizing the strength of memes and “Chad” energy.  GIGA is a community run project.

GigaChad

GigaChad is seeing renewed market attention and high social media engagement as investors highlight its cultural persistence and long-term community dedication. The community is buzzing over its recent expansion into consumer health products, fueling active discussions about its potential for long-term growth as a major memecoin contender.

DoorDash, Inc. engages in the design, development, and operation of a food delivery and logistics platform. It serves consumers in the United States, Canada, and Australia. The company was founded by Andy Fang, Tony Xu, Stanley Tang, and Evan Moore on January 12, 2013 and is headquartered in San Francisco, CA.

DoorDash Inc - Ordinary Shares - Class A

DoorDash is experiencing significant market volatility and active investor debate as it approaches its earnings report, with sentiment split between those bullish on the company's long-term expansion into AI and logistics and those concerned about consumer spending habits and high valuations. The community is heavily focused on the stock's recent price swings and whether the platform can maintain its growth narrative amidst stiff competition and broader economic pressures.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is seeing intense investor focus as community members weigh the clinical progress of its obesity pipeline against recent organizational adjustments and litigation, while simultaneously speculating on the timing of a potential buyout or major partnership. The conversation remains heavily driven by the upcoming maintenance dosing study and the high-stakes race to compete with established GLP-1 sector leaders.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Mettler-Toledo Q1 Earnings Top Estimates, Sales Increase Y/Y

MTD beats Q1 earnings estimates as sales increase 7% year over year, while management lifts full-year 2026 adjusted earnings guidance.


Ironwood Stock Down Despite Q1 Earnings and Revenue Beat

IRWD beats Q1 earnings and revenue estimates with Linzess sales surging on strong demand, but shares slide despite better-than-expected results.

VRTX's Alyftrek, Journavx & Casgevy See Strong Momentum in Q1 Earnings

Vertex's new drugs are gaining momentum as Alyftrek tops $1 billion in sales and Journavx prescriptions accelerate.

Nektar Q1 Earnings & Revenues Lag Estimates, Pipeline in Focus

NKTR misses Q1 earnings and revenue estimates. Investor focus stays on rezpeg as the company advances late-stage studies in autoimmune diseases.

PBYI Q1 Earnings & Sales Beat Estimates, 2026 Guidance Raised

Puma Biotechnology beats Q1 earnings and revenue estimates while raising its 2026 outlook.

Philips Q1 Earnings and Revenues Decrease Year over Year, Shares Up

PHG stock gains after Philips posts Q1 earnings, with 4% comparable sales growth and improved cash flow despite lower revenues.


Viatris Q1 EPS Beats Estimates, Revenues up 8% Driven by Greater China

VTRS beats Q1 estimates as revenues climb 8% on strong Greater China and brands sales, while management reaffirms 2026 guidance.

ADMA Q1 EPS Jumps 73% Y/Y, Revenues Slip, 2026 View Down

ADMA cuts its 2026 outlook after Q1 revenues slip amid IG market pressure, though Asceniv demand and margins stay strong.

WAT Q1 Earnings Beat Estimates, BD Acquisition Aids Revenues

Waters crushes Q1 2026 estimates as revenues surge 91.5%; newly acquired BD units top targets early, and 2026 guidance moves higher.


Zoetis Q1 Earnings Lag Estimates, 2026 View Cut, Stock Down

ZTS misses on Q1 earnings and cuts its 2026 revenue outlook as weaker U.S. companion animal sales pressured results, sending shares down in pre-market trading.

This account has been verified as an official AGEN representative.

Verified Account

Agenus Communications

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.

Agenus Inc

Up > 1%

Flat +/- 1%

Down > 1%

Where does the $SPY finish next week vs. Friday’s close?

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	$2.10	--	--	N/A
Q4 '25	-$1.04	--	--	N/A
Q3 '25	$2.20	$1.94	-11.68%	MISSED
Q2 '25	$2.42	-$1.00	-141.32%	MISSED
Q1 '25	-$1.65	-$1.03	37.73%	BEAT

AGEN
Agenus Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest AGEN News

AGENAgenus Inc